Literature DB >> 1104410

Antibodies to Escherichia coli in chronic liver diseases.

A E Simjee, J M Hamilton-Miller, H C Thomas, W Brumfitt, S Sherlock.   

Abstract

Patients with chronic active hepatitis or alcoholic cirrhosis have serum antibodies to many more serotypes of Escherichia coli than do patients with primary biliary cirrhosis or cryptogenic cirrhosis, or normal controls. They also have antibodies against more serotypes than cirrhotic patients with a portacaval shunt. These observations suggest that factors other than shunting of blood away from the liver are responsible for the increased range of antibodies. These factors are discussed. There was no correlation between the number of serotypes to which antibodies were present and the serum immunoglobulin concentration. In three patients, each with chronic active hepatitis, the antibodies were predominantly of the IgM class, while the elevation of globulin in general was mainly due to increased IgG and IgA levels. Antibodies to Escherichia coli, therefore, probably contribute only a small part of the increased globulin levels found in patients with chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104410      PMCID: PMC1413116          DOI: 10.1136/gut.16.11.871

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  SERUM-ANTIBODY LEVELS AS AN INDICATION OF CLINICALLY INAPPARENT PYELONEPHRITIS.

Authors:  A PERCIVAL; W BIRUMFITT; J DELOUVOIS
Journal:  Lancet       Date:  1964-11-14       Impact factor: 79.321

2.  IMMUNOGLOBULINS OF THE GERMFREE GUINEA PIG.

Authors:  S SELL
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

3.  RELATIONSHIP BETWEEN GAMMA-GLOBULIN METABOLISM AND LOW SERUM GAMMA-GLOBULIN IN GERMFREE MICE.

Authors:  S SELL; J L FAHEY
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

4.  Studies with radioactive endotoxin. II. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with radioactive sodium chromate.

Authors:  A I BRAUDE; F J CAREY; M ZALESKY
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

5.  Antibodies to Escherichia coli in alcoholic and non-alcoholic patients with cirrhosis of the liver or fatty liver.

Authors:  H Prytz; M Björneboe; F Orskov; M Hilden
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

6.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

7.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy.

Authors:  K Sahiar; R S Schwartz
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

10.  Studies of hyperimmunization.

Authors:  C L Christian; J L Abruzzo; A R DeSimone; E L Howes
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

View more
  10 in total

Review 1.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

2.  Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity.

Authors:  N Krasner; M Davis; B Portmann; R Williams
Journal:  Br Med J       Date:  1977-06-11

3.  The immune response in hepatic cirrhosis: animal and human studies.

Authors:  H C Thomas
Journal:  Proc R Soc Med       Date:  1977-08

Review 4.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

5.  Escherichia coli antibodies in patients with inflammatory bowel disease.

Authors:  S Tabaqchali; D P O'Donoghue; K A Bettelheim
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

6.  Hepatitis Bs antibody in alcoholic cirrhosis.

Authors:  P R Mills; T H Pennington; P Kay; R N MacSween; G Watkinson
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

Review 7.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

8.  Anti-albumin antibodies in sera of patients with liver disease.

Authors:  N Tamura; T Suou; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1982-10

9.  Hyperglobulinaemia in chronic liver disease: relationships between in vitro immunoglobulin synthesis, short lived suppressor cell activity and serum immunoglobulin levels.

Authors:  P B Rong; J Kalsi; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.

Authors:  G Pomier-Layrargues; P M Huet; G Richer; D Marleau; A Viallet
Journal:  Dig Dis Sci       Date:  1980-07       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.